Sildenafil activates antioxidant and antiapoptotic genes and inhibits proinflammatory cytokine genes in a rat model of renal ischemia/reperfusion injury

Int Urol Nephrol. 2015 Nov;47(11):1907-15. doi: 10.1007/s11255-015-1099-5. Epub 2015 Sep 16.

Abstract

Objectives: To study the possible renoprotective effect of sildenafil against renal ischemia/reperfusion (I/R) injury and its effect on the expression of some antioxidant, antiapoptotic gene and proinflammatory cytokine genes in rat model of renal I/R injury.

Materials and methods: One hundred and twenty male Sprague Dawley rats were subdivided into three equal groups: sham (underwent right nephrectomy without ischemia), control (underwent right nephrectomy and left ischemia for 45 min) and study [as control with 1 mg/kg sildenafil (per oral) 60 min before anesthesia]. Serum creatinine and BUN were measured at the baseline and the study endpoints (2, 24, 48 h and 7 days), and the left kidney was harvested at study endpoints for histopathological examination as well as for assessment of the expression of antioxidant genes (Nrf-2, HO-1 and NQO-1), antiapoptotic gene (Bcl-2) and inflammatory cytokines, e.g., TNF-a, IL-1β and ICAM-1.

Results: I/R caused significant increase in serum creatinine, BUN, histopathological damage score (p < 0.001) and significant reduction in antioxidant genes (nrf2, HO-1 and NQO-1) and antiapoptotic gene (Bcl2) with significant increase in TNF-a, IL-1β and ICAM-1 genes in kidney tissues. Pretreatment with sildenafil caused significant attenuation of serum creatinine and BUN as well as significant increase in the expression of antioxidant genes and Bcl-2 genes with significant reduction in the expression of proinflammatory cytokine genes (p value < 0.001).

Conclusion: The renoprotective effect of sildenafil against renal I/R might be due to the activation of antioxidant genes (Nrf2, HO-1 and NQO-1) and antiapoptotic gene (Bcl2) and attenuation of proinflammatory cytokines (TNF-a, IL-1β and ICAM-1).

Keywords: Bcl-2; HO-1; Ischemia/reperfusion; Kidney; NQO-1; Nrf2; Sildenafil.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Urea Nitrogen
  • Creatinine / blood
  • Disease Models, Animal
  • Gene Expression / drug effects
  • Heme Oxygenase-1 / genetics
  • Intercellular Adhesion Molecule-1 / genetics
  • Interleukin-1beta / genetics
  • Male
  • NAD(P)H Dehydrogenase (Quinone) / genetics
  • NF-E2-Related Factor 2 / genetics
  • Nephrectomy
  • Phosphodiesterase 5 Inhibitors / pharmacology*
  • Phosphodiesterase 5 Inhibitors / therapeutic use
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury / genetics*
  • Reperfusion Injury / pathology
  • Reperfusion Injury / prevention & control*
  • Sildenafil Citrate / pharmacology*
  • Sildenafil Citrate / therapeutic use
  • Tumor Necrosis Factor-alpha / genetics
  • Warm Ischemia / adverse effects

Substances

  • Interleukin-1beta
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, rat
  • Phosphodiesterase 5 Inhibitors
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Necrosis Factor-alpha
  • Intercellular Adhesion Molecule-1
  • Creatinine
  • Sildenafil Citrate
  • Heme Oxygenase-1
  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, rat